Press Releases
Company News
View Summary Medivation Names Marion McCourt Chief Operating Officer
Jan 11, 2016
PDF 10.9 KB Add to Briefcase
View Summary NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to Develop Novel Companion Diagnostic Test
Jan 7, 2016
PDF 72.8 KB Add to Briefcase
View Summary Medivation to Present at J.P. Morgan Healthcare Conference
Jan 4, 2016
PDF 9.1 KB Add to Briefcase
View Summary Medivation Initiates Pivotal Clinical Trial of MDV9300 in Diffuse Large B-Cell Lymphoma
Dec 21, 2015
PDF 11.8 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
Nov 6, 2015
PDF 9.1 KB Add to Briefcase
View Summary Medivation Reports Third Quarter 2015 Financial Results
Nov 5, 2015
PDF 187.6 KB Add to Briefcase
View Summary Medivation Announces Third Quarter 2015 Financial Results Teleconference on November 5, 2015
Oct 22, 2015
PDF 9.1 KB Add to Briefcase
View Summary Medivation Announces Management Changes
Sep 29, 2015
PDF 12.5 KB Add to Briefcase
View Summary Updated Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 European Cancer Congress
Sep 26, 2015
PDF 62.7 KB Add to Briefcase
View Summary Medivation Effects a Stock Dividend on Its Common Stock
Sep 16, 2015
PDF 8.6 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
Sep 3, 2015
PDF 9.2 KB Add to Briefcase
View Summary Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin
Aug 24, 2015
PDF 15.3 KB Add to Briefcase
View Summary Medivation Reports Second Quarter 2015 Financial Results
Aug 6, 2015
PDF 189.3 KB Add to Briefcase
View Summary Medivation Announces Second Quarter 2015 Financial Results Teleconference on August 6, 2015
Jul 16, 2015
PDF 9.0 KB Add to Briefcase
View Summary Medivation Voted Three Years in a Row Among Top Workplaces in the San Francisco Bay Area
Jun 29, 2015
PDF 9.7 KB Add to Briefcase
View Summary Medivation to Redeem Outstanding Convertible Notes Due 2017
Jun 19, 2015
PDF 9.5 KB Add to Briefcase
View Summary Medivation and Astellas Announce Enrollment of the First Patients in Advanced Prostate Cancer Outcomes Registry
Jun 17, 2015
PDF 13.3 KB Add to Briefcase
View Summary New Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 American Society of Clinical Oncology Annual Meeting
Jun 1, 2015
PDF 163.0 KB Add to Briefcase
View Summary Medivation Names Andrew Powell General Counsel
May 28, 2015
PDF 10.3 KB Add to Briefcase
View Summary Medivation and Astellas Announce New Enzalutamide Data Presented at the 2015 American Urology Association Annual Meeting
May 17, 2015
PDF 157.9 KB Add to Briefcase
Showing 21-40 of 368 Page: 1 2 3 4 5 6 ... 19  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Top